Researchers have retracted a paper about a new molecular target for cancer after realizing they had mistaken the identity of their cell line.
It’s all too easy to mix up cell lines, so we see plenty of retractions for that reason — and, according to an expert in the area, many more cases lurk uncorrected in the literature.
The retraction notice for “Knockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma” in Cell Biology International explains the authors’ perspective on this case:





If you need evidence of the value of transparency in science, check out a pair of recent corrections in the structural biology literature.
Four different journals have pulled papers from the same authors due to alleged duplication or manipulation of images.